Literature DB >> 693549

Stress-produced analgesia and morphine-produced analgesia: lack of cross-tolerance.

R J Bodnar, D D Kelly, S S Steiner, M Glusman.   

Abstract

Animals exposed to cold-water swims, rotation, inescapable shocks, abrupt food deprivation and other stressors display temporary analgesia. Since repeated exposures result in adaptation of this analgesia in much the same way that repeated administration of opiates results in tolerance, the possibility of cross-tolerance between cold-water stress-induced and morphine-induced analgesia was investigated. Flinch-jump thresholds were determined in ten experimental groups of six rats each. Three groups showed dose-dependent analgesia following single injections of morphine at 5, 10 and 15 mg/kg, respectively. A fourth group, subjected to a single cold-water swim at 2 degrees C for 3.5 min, displayed analgesia comparable to that produced by 10 mg/kg of morphine. Groups subjected either to 14 daily cold-water swims or to 14 daily morphine injections at 10 mg/kg showed normal thresholds on the 14th day indicating that adaptation and tolerance had developed, respectively. The cross-over groups were exposed to either 13 days of could-water swims followed by morphine or the reverse arrangement. Both groups showed profound analgesia instead of cross-tolerance, suggesting that a non-opiate neural mechanism may mediate stress-induced analgesia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 693549     DOI: 10.1016/0091-3057(78)90263-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Stress-induced analgesia and endogenous opioid peptides: the importance of stress duration.

Authors:  Drupad Parikh; Abdul Hamid; Theodore C Friedman; Khanh Nguyen; Andy Tseng; Paul Marquez; Kabirullah Lutfy
Journal:  Eur J Pharmacol       Date:  2010-10-31       Impact factor: 4.432

2.  Swim-stress-induced antinociception in young rats.

Authors:  H C Jackson; I Kitchen
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

3.  Endorphin-induced hyperthermia: characterization of the exogenously and endogenously induced effects.

Authors:  J Bläsig; U Bäuerle; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

4.  A Neural Circuit for the Suppression of Pain by a Competing Need State.

Authors:  Amber L Alhadeff; Zhenwei Su; Elen Hernandez; Michelle L Klima; Sophie Z Phillips; Ruby A Holland; Caiying Guo; Adam W Hantman; Bart C De Jonghe; J Nicholas Betley
Journal:  Cell       Date:  2018-03-22       Impact factor: 41.582

5.  Effects of corticoliberin CRF(4-6) fragment on pain sensitivity in rats.

Authors:  E Yu Makarenko; L A Andreeva; A A Mart'yanov
Journal:  Neurosci Behav Physiol       Date:  2007-01

6.  Post-natal morphine differentially affects opiate and stress analgesia in adult rats.

Authors:  D Arjune; R J Bodnar
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.

Authors:  Stephen Bruehl; John W Burns; Rajnish Gupta; Asokumar Buvanendran; Melissa Chont; Erik Schuster; Christopher R France
Journal:  Reg Anesth Pain Med       Date:  2014 Mar-Apr       Impact factor: 6.288

8.  Eating is a protected behavior even in the face of persistent pain in male rats.

Authors:  H Foo; Katherine Crabtree; Ama Thrasher; Peggy Mason
Journal:  Physiol Behav       Date:  2009-03-24

9.  Naloxone injections into the periaqueductal grey area and arcuate nucleus block analgesia in defeated mice.

Authors:  K A Miczek; M L Thompson; L Shuster
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Chlordiazepoxide antinociception: cross-tolerance with opiates and with stress.

Authors:  R J Bodnar; D D Kelly; L W Thomas; A Mansour; M Brutus; M Glusman
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.